Founded in 2016 and headquartered in Menlo Park, California, Akoya Biosciences (NASDAQ:AKYA) is a global leader in spatial biology solutions designed to accelerate the discovery and development of novel therapeutics. The company’s core mission is to provide researchers and pathologists with the tools necessary to visualize and quantify the spatial relationships of proteins, RNA, and other biomarkers in intact tissues, advancing our understanding of complex diseases such as cancer and autoimmune disorders.
Akoya’s product portfolio includes the CODEX (CO-Detection by indEXing) system, which enables highly multiplexed, single-cell imaging of formalin-fixed, paraffin-embedded (FFPE) and fresh-frozen tissue sections. The company also offers the Phenoptics line of immunofluorescence and chromogenic imaging platforms, accompanied by proprietary reagents and software analytics. These integrated solutions support both discovery research and translational studies, facilitating everything from early-stage biomarker identification to companion diagnostic development.
Serving a diverse clientele across academic institutions, pharmaceutical and biotechnology companies, and contract research organizations, Akoya maintains operations in North America, Europe, and the Asia-Pacific region. The company’s global reach is reinforced by strategic partnerships and distribution agreements, ensuring its technologies are accessible to a broad scientific community. Akoya’s instruments and assays have been utilized in hundreds of research publications, underscoring their impact on the life sciences field.
Akoya is led by an experienced management team with deep expertise in life sciences instrumentation and imaging technologies. The leadership group includes veterans from the biotech and pharmaceutical industries, supported by a board of directors committed to driving growth through innovation and customer-centric solutions. Under this guidance, Akoya continues to expand its product offerings and deepen its footprint in the burgeoning spatial biology market.
